Castle Biosciences chief commercial officer Tobin W. Juvenal reports sale of $239,590.828 in common shares
CSTL•Chief Commercial Officer Tobin W. Juvenal sold 6,578 Castle Biosciences common shares on October 28, 2026, and held 38,853 shares directly afterward.
1. Share sale
Juvenal sold 1,237 shares at $35.577 each and 5,341 shares at $36.619 each. His direct beneficial ownership stood at 38,853 common shares following the transactions.
